KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

Clover Health Investments (CLOV) EBIAT (2019 - 2025)

Clover Health Investments' EBIAT history spans 7 years, with the latest figure at -$49.3 million for Q4 2025.

  • For Q4 2025, EBIAT fell 94.56% year-over-year to -$49.3 million; the TTM value through Dec 2025 reached -$85.5 million, down 70.19%, while the annual FY2025 figure was -$85.5 million, 84.91% down from the prior year.
  • EBIAT reached -$49.3 million in Q4 2025 per CLOV's latest filing, down from -$24.4 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $7.4 million in Q2 2024 to a low of -$317.6 million in Q2 2021.
  • Average EBIAT over 5 years is -$59.6 million, with a median of -$34.1 million recorded in 2021.
  • Peak YoY movement for EBIAT: plummeted 9500.0% in 2023, then soared 125.64% in 2024.
  • A 5-year view of EBIAT shows it stood at -$187.2 million in 2021, then surged by 100.4% to $757000.0 in 2022, then tumbled by 9500.0% to -$71.2 million in 2023, then soared by 64.38% to -$25.3 million in 2024, then plummeted by 94.56% to -$49.3 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's EBIAT are -$49.3 million (Q4 2025), -$24.4 million (Q3 2025), and -$10.6 million (Q2 2025).